Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream

Wang, Xuexuan; Black, Laura

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream

Author(s): Wang Xuexuan, Black Laura

Issue: Nov/Dec 2013 - Volume 17, Number 6
View All Articles in Issue

Page(s): 520-525

Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream Page 1

Download in electronic PDF format for $75

Abstract: This ex vivo human percutaneous absorption study evaluated a set of six model drugs (ketamine hydrochloride, bupivacaine hydrochloride, diclofenac sodium, gabapentin, orphenadrine citrate, pentoxifylline) from two popular formulations for topically applied compounding preparations. The compounded preparations used in this study were Versatile cream and a reference cream. Each formulation was applied to human trunk skin mounted on Franz Diffusion Cells, 50 mg/chamber (or 28.2 mg/cm2). Serial dermal receiver solutions were collected for 48 hours. Analysis of the resultant data supports the concept that the Versatile base formulation provides improved characteristics relative to the reference base. This is of key importance where the patient does not show clinical improvement when a conventional topical delivery vehicle is used in the formulation. From the results, it is reasonable to anticipate that, relative to the reference formulation, the Versatile formulation provides enhanced transdermal delivery of some analgesic medications

Related Keywords: Xuexuan Wang, PhD, Laura Black, BSc, ketamine, bupivacaine, diclofenac, gabapentin, orphenadrine, pentoxifylline, topical preparations, transdermal absorption, percutaneous absorption, skin penetration enhancers, analgesic, pain medication, versatile cream base, drug release rate, drug delivery

Related Categories: EXCIPIENTS, PAIN MANAGEMENT, PEER-REVIEWED, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream Wang Xuexuan, Black Laura	Nov/Dec 2013 Pg. 520-525
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream Lehman Paul A, Raney Sam G	May/Jun 2012 Pg. 248-252
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B	Jul/Aug 2014 Pg. 332-340
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Allen Loyd V Jr	May/Jun 2016 Pg. 231
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Allen Loyd V Jr	Mar/Apr 2024 Pg. 135
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes Trissel Lawrence A, Xu Quanyun A, Pham Lien	Jan/Feb 2002 Pg. 70-73
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah	Jul/Aug 2021 Pg. 336-343
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Trimble John, Light Bob	May/Jun 2016 Pg. 250-256
Clonidine HCl 0.2%, Gabapentin 6%, and Ketamine HCl 10% in a Pluronic Lecithin Organogel (PLO) Allen Loyd V Jr	Jan/Feb 2002 Pg. 42
Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO Allen Loyd V Jr	Mar/Apr 2000 Pg. 133
Ketamine 10 %, Gabapentin 6%, and Nifedipine 2% in PLO Meece Jerry	May/Jun 2003 Pg. 171
Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO) Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 185
Case Study: Absorption of Testosterone Cream via Scrotal Delivery Needham Shawn, Needham Shane	Nov/Dec 2018 Pg. 466-468
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard	Mar/Apr 2020 Pg. 168-175
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases Allen Loyd V Jr	May/Jun 2017 Pg. 238
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Shakshuki Ayah, Agu Remigius U	Nov/Dec 2019 Pg. 496-503
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso	Mar/Apr 2021 Pg. 146-155
Skin Penetration and Antinociception of Topical Gabapentin Formulations Bryson Evan, Asbill Scott, Sweitzer Sarah	Nov/Dec 2014 Pg. 504-511
Bupivacaine Hydrochloride 0.5% Injection Allen Loyd V Jr	May/Jun 2014 Pg. 234
Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 155
Return to Top